Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Polypoidal choroidal vasculopathy: an update on therapeutic approaches.

Wong RL, Lai TY.

J Ophthalmic Vis Res. 2013 Oct;8(4):359-71. Review.

2.

Photodynamic therapy for polypoidal choroidal vasculopathy.

Nowak-Sliwinska P, van den Bergh H, Sickenberg M, Koh AH.

Prog Retin Eye Res. 2013 Nov;37:182-99. doi: 10.1016/j.preteyeres.2013.09.003. Review.

3.

[Polypoidal choroidal vasculopathy].

Yuzawa M.

Nippon Ganka Gakkai Zasshi. 2012 Mar;116(3):200-31; discussion 232. Review. Japanese.

PMID:
22568102
4.

An Update in Laser and Pharmaceutical Treatment for Polypoidal Choroidal Vasculopathy.

Lai TY, Chan WM.

Asia Pac J Ophthalmol (Phila). 2012 Mar-Apr;1(2):97-104. doi: 10.1097/APO.0b013e31823e5a95.

5.

Polypoidal choroidal vasculopathy - a type I polypoidal subretinal neovasculopathy.

Kokame GT.

Open Ophthalmol J. 2013 Oct 31;7:82-4. doi: 10.2174/1874364101307010082.

6.
7.

Refractory neovascular age-related macular degeneration secondary to polypoidal choroidal vasculopathy.

Cho M, Barbazetto IA, Freund KB.

Am J Ophthalmol. 2009 Jul;148(1):70-8.e1. doi: 10.1016/j.ajo.2009.02.012.

PMID:
19403115
9.
11.

Marked vascular changes of polypoidal choroidal vasculopathy after photodynamic therapy.

Wakabayashi T, Gomi F, Sawa M, Tsujikawa M, Tano Y.

Br J Ophthalmol. 2008 Jul;92(7):936-40. doi: 10.1136/bjo.2007.132357.

PMID:
18577645
12.

Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy.

Lai TY, Chan WM, Liu DT, Luk FO, Lam DS.

Br J Ophthalmol. 2008 May;92(5):661-6. doi: 10.1136/bjo.2007.135103.

PMID:
18356265
13.

[Age-related Macular Degeneration in the Japanese].

Yoshimura N.

Nippon Ganka Gakkai Zasshi. 2016 Mar;120(3):163-88; discussion 189. Japanese.

PMID:
27164756
14.

Polypoidal choroidal vasculopathy: a common type of neovascular age-related macular degeneration in Caucasians.

Yadav S, Parry DG, Beare NA, Pearce IA.

Br J Ophthalmol. 2017 Mar 7. pii: bjophthalmol-2016-310074. doi: 10.1136/bjophthalmol-2016-310074. [Epub ahead of print]

PMID:
28270486
15.

Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.

Chan WM, Lam DS, Lai TY, Liu DT, Li KK, Yao Y, Wong TH.

Ophthalmology. 2004 Aug;111(8):1576-84.

PMID:
15288991
16.
17.

Polypoidal choroidal vasculopathy: natural history.

Uyama M, Wada M, Nagai Y, Matsubara T, Matsunaga H, Fukushima I, Takahashi K, Matsumura M.

Am J Ophthalmol. 2002 May;133(5):639-48.

PMID:
11992861
18.

Polypoidal choroidal vasculopathy.

McCleary CD, Guier CP, Dunbar MT.

Optometry. 2004 Dec;75(12):756-70.

PMID:
15624672
19.

[Choroidal Neovascularisation Other than Typical Neovascular Age-Related Macular Degeneration].

Sandner D.

Klin Monbl Augenheilkd. 2017 Mar 10. doi: 10.1055/s-0042-123833. [Epub ahead of print] German.

PMID:
28282700
20.

Polypoidal choroidal vasculopathy masquerading as neovascular age-related macular degeneration refractory to ranibizumab.

Stangos AN, Gandhi JS, Nair-Sahni J, Heimann H, Pournaras CJ, Harding SP.

Am J Ophthalmol. 2010 Nov;150(5):666-73. doi: 10.1016/j.ajo.2010.05.035.

PMID:
20719300

Supplemental Content

Support Center